Statistics Applied to Clinical TrialsSpringer Science & Business Media, 2006 - Broj stranica: 366 The previous two editions of this book, rather than being comprehensive, concentrated on the most relevant aspects of statistical analysis. Although well-received by students, clinicians, and researchers, these editions did not answer all their questions. This updated and extended edition serves as a more complete guide and reference text to students, physicians, and investigators, and, at the same time, preserves the common sense approach to statistical problem-solving of the previous editions. |
Sadržaj
III | 1 |
IV | 2 |
V | 3 |
VI | 8 |
VII | 11 |
VIII | 13 |
IX | 14 |
X | 15 |
CXXI | 190 |
CXXII | 191 |
CXXIV | 193 |
CXXV | 196 |
CXXVI | 198 |
CXXVII | 203 |
CXXIX | 204 |
CXXX | 205 |
XII | 16 |
XIII | 17 |
XIV | 18 |
XV | 21 |
XVI | 22 |
XVII | 24 |
XVIII | 25 |
XIX | 28 |
XX | 30 |
XXI | 36 |
XXII | 39 |
XXIV | 41 |
XXV | 42 |
XXVI | 48 |
XXVII | 51 |
XXVIII | 52 |
XXIX | 54 |
XXX | 57 |
XXXII | 59 |
XXXIII | 61 |
XXXIV | 62 |
XXXV | 63 |
XXXVII | 64 |
XXXVIII | 65 |
XXXIX | 67 |
XL | 68 |
XLI | 70 |
XLII | 71 |
XLIII | 73 |
XLV | 76 |
XLVI | 78 |
XLVIII | 79 |
XLIX | 80 |
L | 83 |
LII | 85 |
LIV | 87 |
LV | 92 |
LVI | 95 |
LVIII | 97 |
LIX | 98 |
LX | 99 |
LXII | 100 |
LXIV | 101 |
LXVI | 103 |
LXVII | 104 |
LXVIII | 106 |
LXX | 107 |
LXXI | 108 |
LXXII | 109 |
LXXIII | 110 |
LXXIV | 111 |
LXXVI | 113 |
LXXVIII | 117 |
LXXIX | 118 |
LXXX | 119 |
LXXXI | 122 |
LXXXIII | 125 |
LXXXIV | 126 |
LXXXV | 129 |
LXXXVI | 131 |
LXXXVII | 133 |
LXXXVIII | 137 |
LXXXIX | 138 |
XC | 140 |
XCI | 141 |
XCII | 142 |
XCIII | 144 |
XCIV | 145 |
XCV | 146 |
XCVI | 147 |
XCVII | 148 |
XCVIII | 149 |
C | 150 |
CI | 151 |
CII | 152 |
CIII | 154 |
CIV | 160 |
CV | 162 |
CVII | 165 |
CVIII | 169 |
CIX | 171 |
CX | 174 |
CXI | 175 |
CXII | 177 |
CXIV | 179 |
CXV | 181 |
CXVI | 182 |
CXVII | 183 |
CXVIII | 185 |
CXX | 187 |
CXXXI | 206 |
CXXXII | 208 |
CXXXV | 209 |
CXXXVI | 217 |
CXXXVII | 218 |
CXXXIX | 219 |
CXL | 220 |
CXLI | 221 |
CXLII | 223 |
CXLIII | 226 |
CXLIV | 227 |
CXLV | 228 |
CXLVI | 229 |
CXLVII | 230 |
CXLVIII | 231 |
CL | 232 |
CLI | 234 |
CLII | 235 |
CLIII | 236 |
CLV | 239 |
CLVI | 241 |
CLVIII | 243 |
CLIX | 245 |
CLX | 246 |
CLXI | 247 |
CLXII | 248 |
CLXIII | 249 |
CLXIV | 251 |
CLXV | 252 |
CLXVI | 253 |
CLXVII | 254 |
CLXVIII | 257 |
CLXIX | 258 |
CLXXI | 261 |
CLXXII | 262 |
CLXXIII | 264 |
CLXXIV | 265 |
CLXXV | 269 |
CLXXVII | 271 |
CLXXVIII | 272 |
CLXXIX | 274 |
CLXXX | 276 |
CLXXXI | 278 |
CLXXXIII | 279 |
CLXXXIV | 282 |
CLXXXV | 283 |
CLXXXVII | 285 |
CLXXXVIII | 291 |
CLXXXIX | 293 |
CXC | 294 |
295 | |
CXCII | 297 |
CXCIII | 298 |
CXCIV | 299 |
CXCV | 301 |
CXCVI | 302 |
CXCVII | 304 |
CXCVIII | 305 |
CC | 307 |
CCI | 310 |
CCII | 312 |
CCIV | 316 |
CCVI | 317 |
CCVII | 319 |
CCVIII | 321 |
CCIX | 323 |
CCX | 327 |
CCXI | 328 |
CCXIII | 329 |
CCXIV | 330 |
CCXV | 331 |
CCXVI | 333 |
CCXVII | 335 |
CCXVIII | 336 |
CCXX | 337 |
CCXXI | 338 |
CCXXIV | 339 |
CCXXV | 340 |
CCXXVII | 341 |
CCXXIX | 342 |
CCXXX | 343 |
CCXXXI | 345 |
CCXXXII | 346 |
CCXXXIV | 347 |
CCXXXV | 348 |
CCXXXVII | 350 |
CCXXXIX | 353 |
361 | |
Ostala izdanja - Prikaži sve
Statistics Applied to Clinical Trials Ton J. Cleophas,A.H. Zwinderman,T.F. Cleophas,Toine F. Cleophas,Eugene P. Cleophas Ograničeni pregled - 2016 |
Uobičajeni izrazi i fraze
ABPM angina pectoris ANOVA assessment b₁ b₂ beta-blockers better Bonferroni calcium calculated carryover effect chance chapter Cleophas TJ clinical trials compared CONCLUSIONS confidence intervals continuous data correlation coefficient covariates crossover studies curve degrees of freedom demonstrated disease drug endpoint equivalence estimate example factors Figure frequency distribution genes graph hypertension hypothesis interaction interim analyses LDL cholesterol linear regression logistic regression mean result Medical medicine meta-analyses methods mmol/l multiple negative correlation normal distribution null numbers of patients observed odds ratio otherwise called p-value paired parallel-group placebo polynomes population positive correlation pravastatin procedure proportions protocol randomized controlled trials regression analysis regression line regression model reject the null-hypothesis reproducibility response risk scores SEMS sensitivity significantly different square standard deviation standard error statistical power statistical tests statistically significant t-distribution t-table t-test Table treatment difference treatment effect treatment groups type I error unpaired values variance versus x-axis X₁ zero